Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation correlation of pathologic parameters with outcome of treatment
โ Scribed by Lawrence J. Solin; I-Tien Yeh; John Kurtz; Alain Fourquet; Abram Recht; Robert Kuske; Beryl McCormick; Michael A. Cross; Delray J. Schultz; Robert Amalric; Virginia A. Livolsi; Michael J. Kowalyshyn; Joachim Torhorst; Jocelyne Jacquemier; Cindy D. Westermann; Gwen Mazoujian; Brigitte Zafrani; Paul P. Rosen; Robert L. Goodman; Barbara L. Fowble
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 937 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND: The purpose of this study was to determine the ipsilateral breast tumor recurrence (IBTR) in ductal carcinoma in situ (DCIS) patients treated in the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial who met the criteria for E5194 treated w
## BACKGROUND. Although in recent years there has been a dramatic increase in both the incidence of ductal carcinoma in situ (DCIS) and breast-conserving therapy for patients who have this disease, the optimal treatment for these patients remains controversial. Most data regarding outcomes have co
## BACKGROUND. Although histologic grade has previously been described as a predictor of distant failure, it xs uncertain whether histologic grade should be used to decide which patients should undergo axillary lymph node dissection and whether grade should be considered as a selection factor for